9-(dimethylaminoethoxy)ellipticine
modulates MYC expression; has potential as an antineoplastic agent for the treatment of multiple myeloma; structure in first source
Also Known As:
EPED3 cpd; GQC-05; NSC 338258; NSC-338258; NSC338258
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Gokhale, Vijay:
2 articles
(12/2019 - 11/2011)
|
2. | Hurley, Laurence H:
2 articles
(12/2019 - 11/2011)
|
3. | Arceci, Robert J:
1 article
(12/2019)
|
4. | Azorsa, David O:
1 article
(12/2019)
|
5. | Lee, David W:
1 article
(12/2019)
|
6. | Montoya, Justin J:
1 article
(12/2019)
|
7. | Patel, Apurvi R:
1 article
(12/2019)
|
8. | Turnidge, Megan A:
1 article
(12/2019)
|
9. | Wai, Daniel H:
1 article
(12/2019)
|
10. | Wetmore, Cynthia:
1 article
(12/2019)
|
Related Diseases
Related Drugs and Biologics